The treatment of Cancer Risk Reduction & Hemophilia with vitamins

Cancer Risk Reduction and Hemophilia: Mitamins custom make quality formulas for the treatment of Cancer Risk Reduction & Hemophilia with vitamins. A Cancer Risk Reduction & Hemophilia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cancer Risk Reduction and Hemophilia

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    500
    mg
    833%
    Vitamin E
    100
    IU
    333%
    Vitamin K
    50
    mcg
    63%
    Thiamin
    50
    mg
    3333%
    Riboflavin
    50
    mg
    2941%
    Niacin
    50
    mg
    250%
    Vitamin B6
    50
    mg
    2500%
    Folate
    400
    mcg
    100%
    Vitamin B12
    50
    mcg
    833%
    Biotin
    50
    mcg
    17%
    Pantothenic Acid
    50
    mg
    500%
  • Amount Per Serving
    % DV
    Calcium
    200
    mg
    20%
    Magnesium
    100
    mg
    25%
    Choline Bitartrate
    50
    mg
    *
    Inositol
    50
    mg
    *
    PABA
    50
    mg
    *
    CoQ-10
    15
    mg
    *
    Bioflavonoid Concentrate
    100
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    50
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cancer Risk Reduction and Hemophilia
Serving Size:4-5

Cancer Risk Reduction and Hemophilia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Catheter Angiography May Be An Unnecessary Follow Up To CT Angiography For Some Blunt Trauma Patients
Even in challenging cases, CT angiography (CTA) offers an accurate and rapid diagnosis for blunt trauma victims who may have aortic or great vessel injury negating the need for more invasive procedures, according to a recent study conducted by radiologists at the University of Washington and the Harborview Injury Prevention and Research Center in Seattle, WA.
Siemens Medical Solutions Increases Presence In Japan: Joint Venture With Kameda Healthinformatics Institute For Healthcare IT
Siemens Medical Solutions and Kameda Healthinformatics Institute Inc. announced the establishment of a joint venture company which will be named Siemens Kameda Healthcare IT Systems K.K., effective recently. Siemens Medical Solutions will hold two-thirds ownership and Kameda Healthinformatics Institute will hold one-third ownership of the newly formed company. The establishment of Siemens Kameda Healthcare IT Systems K.K.
This information concerning the support of Cancer Risk Reduction and Hemophilia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments